Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
She said that management sat down with the major tutes and they were behind the science and management. And like a week or so later Adage dumped. She didn’t specifically say Adage but who else could be the major institutions. This was was before fidelity dumped as well. It was around Sept.
FWIW IG. She told me the same thing and it was obviously around the same timeframe as Adage sold or delivered afterward.(her email that I received).
You can have a net loss of 3000 max from your overall portfolio. If you have 10000 in option losses use them to offset any gains first just like a stock sale.
https://finance.zacks.com/can-claim-loss-unexercised-stock-options-1177.html
Interesting comment. I wonder if he’s still in the know.
Steve. One way to cover and drop share price is to induce a fairly quick/steep drop in price which can trigger retails that have stop losses on the shares. This will automatically sell their shares and the short scoops up those shares in addition to the shares used to cause the drop. Since stop losses are always lower than current price they can pretty much run this all the way down as they have and as long as people continue to use stops. Just one example.
To expound on this - in a perfect world announce the partnership first and then EU submission imo. The partnership is the ambiguous factor as of now and announcing first would give the stock a push and follow up with the known (eu filing). IMO
I agree. It’s sounds like they’re not close to a deal. Some enthusiasm indicating we’ve been making strides towards achieving this goal or something like that.
Noelle, mentioned the 4.5 mill grant will be is cash from NJ
I got some early today for a nickel.
Here’s the interview Gantor referring to
The Amgen milestone payments were not disclosed - for competitive reasoning. Simply meaning that other potential deals can’t use the milestone payments as a negotiating tool.
Not sure about sellas
Cala was as high as 30 down to 2.50 pps and rose last Jan through July as high as 18.
BTW one of their largest holders was Adage
True buts it didn’t increase 30x in value in 12 months after being built either. Maybe double.
I emailed the following:
Also, has there been any attempt or talk of going for accelerated approval in the US for AXAL mono ?
Her response: On Tue, Sep 19, 2017 at 5:03 PM Noelle Heber <heber@advaxis.com> wrote:
The institutional holders we have met with are behind us and the science. At time there is no plan to move forward with the data that we have today for AXAL.
Sounds right. I was just fishing through my emails and her response was dated 9/19- so that is a little while back. Hopefully they’ve made progress
Ig. Noelle told me a month or so ago that AA isn’t something they were ready to apply for at that time. Main focus was EU. now this could’ve changed since then but I doubt it.
My thought is if they’re continually attending these investor conferences rehashing old info there are no serious offers for AXAL at this juncture or their full commitment would be to hammer out a deal. I’m hoping they prove me wrong.
Deadlines mean nothing to ADXS. This place had to be an absolute mess when Dan left. To be fair TL has only been it the driver seat for 5 months so I would expect this to turnaround early next year unless we get that partnership in the next 6 weeks.
I’m sure the pics will be on Twitter like their solar eclipse party was.
https://www.sec.gov/Archives/edgar/data/1100397/000114420413055793/v357681_ex99-1.htm
Here is the SEC filing off google. It’s in the first paragraph.
JB
I’m well aware of that
1 warrant equals the right to one share @ $5 strike price. They expire on 10/18/18 I believe or within a day or two from that date.
If the price is say 10 dollars next summer your warrant will be worth 5 bucks. SP - warrant cost to exercise(5 bucks). You don’t need to convert to shares it will easily be able to be sold if it’s in the money, just like options.
The difference between options and warrants is the warrant is written by the actually company as opposed to options written by a tute or other shareholder.
The fact is the company is run by incompetent management hence the selling. The science is better than good thus far, but these guys have tripped over their feet every step of the way.
They have zero ability to communicate effectively! Which creates doubt and doubt equals sells.
Another example is this last conference rehashing old info in a poster presentation and then having a reception screams to me of desperation looking for partners.
At this point we can hope this more of a CALA scenario than what it actually looks like - a rudderless ship.
What’s the optimum effect if they didn’t cover shorts? To sell at the bottom?
My bad. Sorry about that.
These should be considered ISO. meaning incentive stock option. They are taxed as capital gain at sale. Yes it would be the sale price minus 3.19 in this case.
Dans reckless spending and hiring has a lot to do with where we are SP wise. You can’t just take into acct. shelving her2 with the new regime. The BOD let him run wild for way to long and we paying for it now.
Now I do believe the new management is looking to sell off or partner ASAP which should propel us upward to the point a lot of us can get out.
Nice 9th I believe
Anyone know of the top of their head what management received in options last year for comparison?
If that’s how they did business investing 65 million and then dumping their shares in a year before the trial starts. There would be NO Amgen.
You’re basically saying Amgen out the kindness of their heart gave ADXS 40+25 mill.
Eerily similar it actually hit 30 bucks like us in 2015 according to chart. Down to 2.50 and started its uptrend on a collaboration with Incyte on 1/30/17. It looks like they received 45mill upfront and 8 million equity investment. Nothing special IMO.
Prior to deal they had a 25% reduction in hedgies but of course the devil stayed ADAGE. The uptrend started from that point all year. No reason for the takedown.
If it plays out the same these guys are just scumbags plain and simple.
Cala current cash around 50 million and a cap of 565 mill. FWIW
PEACE
Confirmed today
Wrong. I confirmed with Hans that they do have to disclose being over 5% owner
Or they are all getting out. Can’t be a one sided theory only. This BOD and management has instilled zero confidence. They can’t even close a deal with the best GOG results ever.
Completely inept.
Wouldn’t that be insider trading Steve. Doubt that’s the case
Might be there only way to cover. IMO
http://www.nasdaq.com/article/profit-from-the-5-threshold-with-these-two-stocks-cm17099
I meant Hans. Here is the meat of the email:
I think their goal was to bring their position below 10% - now it’s done. The pushout on the filing is the result of EMA requesting additional information on OTHER trials that GOG has done in this setting. They asked for the data for comparative purposes. Since the data belong to and are being submitted by GOG, Advaxis has no control over the timing, unfortunately.